Tag: HUMIRA (Adalimumab Drug) Market Report
HUMIRA (Adalimumab Drug) Market Size to Grow at a CAGR of 1% During the Forecast Period of 2023-2031
HUMIRA (adalimumab) is a biologic medication that is used to treat a variety of inflammatory conditions, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease.